Astrana Health Quarterly Income Statement
NASDAQ: ASTHConsumer DiscretionaryProfessional ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Astrana Health revenue and earnings
In the quarter ended Jun 30, 2026, Astrana Health generated $972.5 million in revenue, up 48.5% from the same quarter a year earlier. Net income was $19.7 million (+109.5% year over year), for a net margin of 2.0% versus a median of 1.1% in the prior 5 quarters. Gross margin was 10.7% (down from 11.9%) and operating margin 3.5%.
Diluted earnings per share came in at $0.40, up from $0.19.
Summary generated from market data by MetaCap's automated system. Methodology
Astrana Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20252026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 972.52M | 965.10M | 950.53M | 956.05M | 654.81M | 620.39M | 665.21M | 478.71M | 486.26M | 404.36M | 353.04M | 348.17M |
| Revenue growth (YoY) | +48.52% | +55.56% | +42.89% | +99.71% | +34.66% | +53.43% | +88.43% | +37.49% | +39.65% | +19.90% | +20.00% | +9.83% |
| Cost of Revenue | 868.50M | 859.36M | 855.48M | 858.86M | 576.84M | 549.06M | 614.73M | 405.22M | 412.81M | 330.40M | 314.06M | 275.38M |
| Gross Profit | 104.02M | 105.74M | 95.04M | 97.19M | 77.97M | 71.33M | 50.48M | 73.49M | 73.46M | 73.96M | 38.98M | 72.80M |
| Operating Expenses | 69.70M | 77.22M | 76.65M | 77.98M | 57.63M | 50.75M | 49.76M | 45.07M | 43.39M | 43.82M | 42.85M | 33.72M |
| Operating Income | 34.32M | 28.53M | 18.39M | 19.21M | 20.34M | 20.58M | 720.00K | 28.43M | 30.07M | 30.14M | -3.87M | 39.08M |
| Interest Expense | 16.00M | 16.10M | 17.52M | 17.72M | 7.38M | 7.31M | 8.07M | 8.86M | 8.59M | 7.58M | 5.42M | 3.78M |
| Other Income (Expense) | -7.11M | -8.82M | -10.89M | -13.54M | -3.52M | -10.98M | -2.62M | -1.61M | 1.83M | -6.13M | 4.79M | -1.07M |
| Pretax Income | 27.21M | 19.71M | 7.51M | 5.67M | 16.82M | 9.60M | -1.90M | 26.81M | 31.90M | 24.00M | 924.00K | 38.02M |
| Income Tax | 8.76M | 6.58M | 944.00K | 4.59M | 6.61M | 3.38M | 5.88M | 7.83M | 10.03M | 7.14M | 1.02M | 10.04M |
| Net Income | 19.74M | 14.44M | 6.00M | 373.00K | 9.42M | 6.69M | -6.95M | 16.09M | 19.17M | 14.84M | 12.36M | 22.06M |
| Net Income growth (YoY) | +109.48% | +115.72% | — | -97.68% | -50.85% | -54.89% | -156.26% | -27.04% | +45.57% | +12.97% | — | -4.86% |
| EPS (Basic) | 0.40 | 0.30 | 0.12 | 0.01 | 0.19 | 0.14 | -0.14 | 0.34 | 0.40 | 0.31 | 0.27 | 0.47 |
| EPS (Diluted) | 0.40 | 0.29 | 0.12 | 0.01 | 0.19 | 0.14 | -0.14 | 0.33 | 0.40 | 0.31 | 0.26 | 0.47 |
| Shares Outstanding (Basic) | 49.12M | 48.85M | — | 49.22M | 49.19M | 48.47M | — | 47.69M | 47.62M | 47.26M | — | 46.55M |
| Shares Outstanding (Diluted) | 49.78M | 49.05M | — | 49.47M | 49.47M | 48.85M | — | 48.22M | 47.98M | 47.70M | — | 46.92M |
| EBITDA | 49.87M | 44.01M | 34.80M | 34.81M | 27.24M | 27.43M | 8.85M | 35.69M | 37.51M | 35.23M | 1.03M | 43.39M |
| Gross Margin | 10.70% | 10.96% | 10.00% | 10.17% | 11.91% | 11.50% | 7.59% | 15.35% | 15.11% | 18.29% | 11.04% | 20.91% |
| Operating Margin | 3.53% | 2.96% | 1.94% | 2.01% | 3.11% | 3.32% | 11.00% | 5.94% | 6.18% | 7.45% | -110.00% | 11.23% |
| Net Margin | 2.03% | 150.00% | 63.00% | 4.00% | 144.00% | 108.00% | -104.00% | 3.36% | 3.94% | 3.67% | 3.50% | 6.34% |
This table shows 12 quarterly periods of Astrana Health's income statement, from Q2 2026 back to Q3 2023, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ASTH's reporting calendar. What is a income statement?